首页> 外文期刊>CENTREPOINT JOURNAL (Science Edition) >Effectiveness of double disc synergy and disc replacement tests in the confirmation of extended spectrum β-lactamases (ESβLS) production
【24h】

Effectiveness of double disc synergy and disc replacement tests in the confirmation of extended spectrum β-lactamases (ESβLS) production

机译:双重椎间盘协同作用和椎间盘置换试验在确认超广谱β-内酰胺酶(ESβLS)生产中的有效性

获取原文
           

摘要

A total of 500 bacterial isolates (from various sources including stool, urine, sputum, swabs) obtained from Gombe State Specialist Hospital were used for this study. The isolates were separated into Gram positive (200) and Gram negative (300) representing 40% and 60% respectively. Biochemical tests confirmed the Gram negative isolates to be members of the family Enterobacteriaceae which included Klebsiella pneumoniae 60, Escherichia coli 98, Providencia spp. 32, Morganella morganii 32, Shigella spp. 14, Citrobacter freundii 14, Serratia marcescens 10 Salmonella paratyphi A 10, Yersinia enterolitica 8, Proteus vulgaris 4, Salmonella typhi 2 and Pseudomonas aeruginosa 16. Of the 300 Gram negative isolates subjected to screening (using Cefpodoxime (CPX 10μg, Oxoid England) and Cefotaxime (CTX 30μg, Oxoid England} for ESBL-production using the CLSI breakpoint, 250 (83.33%) were found to be positive for ESβLs which included K. pneumoniae 40, E. coli 92, Providencia spp 30, M. morganii 20, P. aeruginosa 14, Shigella spp 14, C. freundii 12, S. marcescens 6, Y. enterocolitica 6, S. paratyphi A 10, P. vulgaris 4 and S. typhi 2. However, one hundred and sixty four, 164 (65.6%) were confirmed (using Amoxicillin-clavulanate, 30μg Oxoid England) to be ESβL-producers based on Disc Replacement Method (DRM) which included K. pneumoniae 32(19.50%), E. coli 52(31.71%), Providencia Spp 20(12.20%), M. morganii 16(9.76%), P. aeruginosa 8(4.88%), Shigella Spp 12(7.32%), C. freundii 6(3.66%), S. marcescens 4(2.44%), S. paratyphi A 8(4.88%), Y. enterocolitica 6(3.66%), P. vulgaris 0, and S. typhi 0. This is higher than those confirmed by Double Disc Synergy Test (DDST) where only 96(38.4%) of ESBL-producers were detected which included K. pneumoniae 20(20.83%), E. coli 26(27.08%), Providencia Spp 14(14.58%), M. morganii 12(12.50%), P. aeruginosa 4(4.17%), Shigella Spp 4(4.17%), C. freundii 2(2.08%), S. marcescens 2(2.08%), S. paratyphi A 4(4.17%), Y. enterocolitica 6(6.25%), P. vugaris 0, and S. typhi 2(2.08%).The prevalence of ESBL producers detected in Gombe State Specialist Hospital based on this research was high and DRM (65.6%) was found to be a more effective confirmatory method than DDST (38.4%) with calculated value (17.78) being greater than the table value (11.07) at P=0.05 using Chi-square statistical analysis.
机译:从贡贝州专科医院获得的总共500种细菌分离株(来自粪便,尿液,痰液,拭子等各种来源)用于这项研究。将分离物分为革兰氏阳性(200)和革兰氏阴性(300),分别代表40%和60%。生化测试证实革兰氏阴性菌是肠杆菌科的成员,其中包括肺炎克雷伯菌60,大肠杆菌98,普罗维登西亚菌。 32,摩根氏摩根氏菌32,志贺氏菌属。 14,弗氏柠檬酸杆菌14,粘质沙雷氏菌10副伤寒沙门氏菌A 10,小肠结肠炎耶尔森氏菌8,寻常变形杆菌4,鼠伤寒沙门氏菌2和铜绿假单胞菌16.经过筛选的300克阴性分离株(使用头孢泊肟(CPX10μg,Oxoid England)和头孢噻肟(CTX30μg,Oxoid England)用于使用CLSI断裂点进行ESBL生产,发现250例(83.33%)的ESβL阳性,包括肺炎克雷伯菌40,大肠杆菌92,普罗维登斯菌30,摩根氏菌20,铜绿假单胞菌14,志贺氏菌属14,弗氏假单胞菌12,marcescens 6,小肠结肠炎耶尔森菌6,副伤寒沙门氏菌A 10,寻常型毕赤酵母4和伤寒沙门氏菌2。但是,一百六十四,164(根据椎间盘置换法(DRM)证实(使用阿莫西林-克拉维酸,30μgOxoid England)为ESβL产生者,其中包括肺炎克雷伯菌32(19.50%),大肠杆菌52(31.71%),普罗维登西亚菌20(12.20%),M。morganii 16(9.76%),铜绿假单胞菌8(4.88%),志贺氏菌12(7.32%),弗氏梭菌6(3.66%),S。marcesc ens 4(2.44%),副伤寒沙门氏菌A 8(4.88%),小肠结肠炎耶尔森菌6(3.66%),寻常型体育杆菌和伤寒沙门氏菌0。这比双盘协同试验(DDST)证实的要高。 ),仅检测到96(38.4%)个ESBL产生者,其中包括肺炎克雷伯菌20(20.83%),大肠杆菌26(27.08%),普罗维登斯菌属14(14.58%),摩根氏菌12(12.50%) ,铜绿假单胞菌4(4.17%),志贺氏菌4(4.17%),弗氏梭菌2(2.08%),marcescens 2(2.08%),副伤寒沙门氏菌A 4(4.17%),小肠结肠炎耶尔森菌6 (6.25%),野性体育(P. vugaris 0)和伤寒沙门氏菌(S. typhi 2)(2.08%)。根据这项研究,在贡贝州专科医院检测到的ESBL生产者患病率很高,而DRM(65.6%)被发现更有效采用卡方统计分析,确定性方法比DDST(38.4%)大,计算值(17.78)大于表值(11.07),P = 0.05。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号